Isoptin 40

Verapamil Hydrochloride, the active ingredient in Isoptin 40, is a calcium channel blocker presented as an oral tablet for oral use. It is employed to lower high blood pressure, relieve chest pain from angina, and control certain abnormal heart rhythms in adult patients.

GNH USA supplies Isoptin 40 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution, ensuring product integrity throughout the supply chain.

Isoptin 40 (verapamil hydrochloride) is used in cardiovascular therapy to manage conditions related to blood pressure and heart rhythm.

- Hypertension: reduces elevated blood pressure by relaxing vascular smooth muscle. - Angina pectoris: alleviates chest pain by decreasing myocardial oxygen demand. - Supraventricular tachycardia: slows abnormal rapid heartbeats by inhibiting cardiac conduction pathways.

Verapamil may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild to moderate pain often occurring at treatment start. - Dizziness or light‑headedness: due to blood pressure lowering. - Flushing: transient warmth and redness of skin. - Constipation: reduced gastrointestinal motility. - Peripheral edema: swelling of ankles or feet. - Nausea: occasional stomach upset.

Serious or Rare Side Effects: - Severe bradycardia: markedly slow heart rate. - Heart block: impairment of electrical conduction. - Hypotension: dangerously low blood pressure. - Acute myocardial infarction: rare heart attack events. - Hepatotoxicity: liver enzyme elevations or injury. - Allergic reactions: rash, itching, or anaphylaxis.

When prescribing Isoptin 40, clinicians should consider several safety measures to minimize risk.

- Cardiac function assessment: evaluate baseline heart rate and conduction before initiation. - Concomitant beta‑blocker use: avoid excessive bradycardia by monitoring combined therapy. - Liver impairment: adjust use in patients with severe hepatic dysfunction. - Renal impairment: use caution in severe kidney disease as clearance may be reduced. - Pregnancy and lactation: prescribe only if benefits outweigh potential risks, as safety data are limited. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture and light.

Verapamil interacts with several medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): can markedly increase verapamil plasma levels. - Digoxin: concurrent use may raise digoxin concentrations, risking toxicity. - Beta‑blockers: combined effect may cause severe bradycardia or heart block.

Moderate Interactions (Monitor Closely): - Antihypertensives (e.g., ACE inhibitors, diuretics): may enhance blood pressure lowering. - Statins metabolized by CYP3A4 (e.g., simvastatin, atorvastatin): increased risk of statin‑related muscle toxicity. - Antacids containing aluminum or magnesium: may reduce oral absorption of verapamil.